Reserved lots of covid “vaccines”
ASE made this Official Information request to Ministry of Health
Ministry of Health did not have the information requested.
From: ASE
Attn Ministry of Health,
I am seeking information relating to any and all covid “vaccines” which have been “reserved” or otherwise specially allocated to designated groups and/or individuals (eg manufacturing lots/batches that were reserved or otherwise set aside for Pfizer employees):
1- I am seeking information that identifies lot/batch numbers, groups, and individuals, relating to any such “reserves” or other special allocations.
2- I am seeking information relating to adverse events associated with such lots/batches (per lot/batch), and how they compare to overall rates of adverse events.
3- I am seeking information relating to the reasoning and justification as to why any lots/batches have been “reserved” or otherwise specially allocated to designated groups and/or individuals.
4- I am seeking all test/QA data for all lots/batches which have been “reserved” or otherwise specially allocated. If any testing that would usually be performed (eg quality and purity testing) was not performed for such “reserved” or otherwise specially allocated lots/batches, please provide information detailing why such tests were not performed.
5- I am seeking information relating to the costs of specially allocating and managing any such “reserves” or other special allocations.
6- I am seeking all other information held by The Ministry of Health relating to any lots/batches which have been “reserved” or otherwise specially allocated to designated groups and/or individuals, and referrals to other parties that may hold such information.
Thank you,
ASE
From: OIA Requests
Kia ora ASE
Thank you for your request for official information. The reference number
for your request is: H2023019065
As required under the Official Information Act 1982, Manatū Hauora will
endeavour to respond to your request no later than 20 working days after
the day your request was received. If you'd like to calculate the
timeframe, you can use the Ombudsman's online calculator
here: [1]http://www.ombudsman.parliament.nz/
If you have any queries related to this request, please do not hesitate to
get in touch.
Ngā mihi
OIA Services Team
Manatū Hauora | Ministry of Health
M[2]inistry of Health information releases
U[3]nite against COVID-19
--------------------------------------------------------------------------
From: ASE <[FOI #21539 email]>
Sent: Tuesday, 10 January 2023 14:09
To: OIA Requests <[email address]>
Subject: Official Information request - Reserved lots of covid “vaccines”
Attn Ministry of Health,
I am seeking information relating to any and all covid “vaccines” which
have been “reserved” or otherwise specially allocated to designated groups
and/or individuals (eg manufacturing lots/batches that were reserved or
otherwise set aside for Pfizer employees):
1- I am seeking information that identifies lot/batch numbers, groups, and
individuals, relating to any such “reserves” or other special allocations.
2- I am seeking information relating to adverse events associated with
such lots/batches (per lot/batch), and how they compare to overall rates
of adverse events.
3- I am seeking information relating to the reasoning and justification as
to why any lots/batches have been “reserved” or otherwise specially
allocated to designated groups and/or individuals.
4- I am seeking all test/QA data for all lots/batches which have been
“reserved” or otherwise specially allocated. If any testing that would
usually be performed (eg quality and purity testing) was not performed for
such “reserved” or otherwise specially allocated lots/batches, please
provide information detailing why such tests were not performed.
5- I am seeking information relating to the costs of specially allocating
and managing any such “reserves” or other special allocations.
6- I am seeking all other information held by The Ministry of Health
relating to any lots/batches which have been “reserved” or otherwise
specially allocated to designated groups and/or individuals, and referrals
to other parties that may hold such information.
Thank you,
ASE
-------------------------------------------------------------------
This is an Official Information request made via the FYI website.
Please use this email address for all replies to this request:
[FOI #21539 email]
Is [Ministry of Health request email] the wrong address for Official Information requests
to Ministry of Health? If so, please contact us using this form:
[4]https://scanmail.trustwave.com/?c=15517&...
Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[5]https://scanmail.trustwave.com/?c=15517&...
If you find this service useful as an Official Information officer, please
ask your web manager to link to us from your organisation's OIA or LGOIMA
page.
show quoted sections
This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway
--------------------------------------------------------------------------
References
Visible links
1. http://www.ombudsman.parliament.nz/
2. https://www.health.govt.nz/about-ministr...
3. https://covid19.govt.nz/
4. https://scanmail.trustwave.com/?c=15517&...
5. https://scanmail.trustwave.com/?c=15517&...
From: OIA Requests
Tçnâ koe ASE
Thank you for your request under the Official Information Act 1982 (the
Act) to Manatû Hauora (the Ministry of Health) on 10 January
2023 for information regarding Comirnaty (Pfizer) COVID-19 Vaccine. You
requested
“…seeking information relating to any and all covid “vaccines” which have
been “reserved” or otherwise specially allocated to designated groups
and/or individuals (eg manufacturing lots/batches that were reserved or
otherwise set aside for Pfizer employees):
1- I am seeking information that identifies lot/batch numbers, groups, and
individuals, relating to any such “reserves” or other special
allocations.
2- I am seeking information relating to adverse events associated with
such lots/batches (per lot/batch), and how they compare to overall rates
of adverse events.
3- I am seeking information relating to the reasoning and justification as
to why any lots/batches have been “reserved” or otherwise specially
allocated to designated groups and/or individuals.
4- I am seeking all test/QA data for all lots/batches which have been
“reserved” or otherwise specially allocated. If any testing that would
usually be performed (eg quality and purity testing) was not performed for
such “reserved” or otherwise specially allocated lots/batches, please
provide information detailing why such tests were not performed.
5- I am seeking information relating to the costs of specially allocating
and managing any such “reserves” or other special allocations.
6- I am seeking all other information held by The Ministry of Health
relating to any lots/batches which have been “reserved” or otherwise
specially allocated to designated groups and/or individuals, and referrals
to other parties that may hold such information.”
No batches of the Comirnaty (Pfizer) COVID-19 vaccine have been reserved
to be allocated to specific groups or individuals. Therefore, your request
is refused in full under section 18(e) of the Act as the information
requested does not exist.
Information about adverse effects following immunisation (AEFI) of the
COVID-19 vaccine is publicly available in Medsafe’s Safety Reports, which
are available at:
[1]www.medsafe.govt.nz/COVID-19/vaccine-report-overview.asp.
Under section 28(3) of the Act, you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [email address] or by calling 0800 802
602.
Nâku noa, nâ
OIA Services Team
Manatû Hauora | Ministry of Health
M[2]inistry of Health information releases
U[3]nite against COVID-19
show quoted sections
References
Visible links
1. http://www.medsafe.govt.nz/COVID-19/vacc...
2. https://www.health.govt.nz/about-ministr...
3. https://covid19.govt.nz/
From: ASE
Attn Ministry of Health,
Thank you for that update.
Please advise where I can find batch-level release assessment (and underlying test/assessment data) of COVID-19 “vaccines” imported into and/or used in New Zealand.
Thank you,
ASE
From: OIA Requests
Kia ora
Please find attached a letter relating to your official information act
request.
Ngā mihi
OIA Services Team
Manatū Hauora | Ministry of Health
M[1]inistry of Health information releases
U[2]nite against COVID-19
show quoted sections
References
Visible links
1. https://www.health.govt.nz/about-ministr...
2. https://covid19.govt.nz/
From: hnzOIA
Tēnā koe,
Thank you for contacting Te Whatu Ora, Health NZ. This is an automatic
reply to confirm that we have received your email. Depending on the
nature of your request you may not receive a response for up to 20 working
days. We will try to respond to your query as quickly as possible.
s information that is identified to be of general public interest, the
response may also be published on our website. If we e response to your
OIA request, all personal information, including your name and contact
details will be removed.
Ngā mihi
Te Whatu Ora, Health NZ.
show quoted sections
From: hnzOIA
Tçnâ koe ASE,
Thank you for your request for information about Covid Batch Level
Assesment on 20 February 2023 . Please find attached our response to your
request.
If you have any questions, please get in touch
at [1][email address].
If you are not happy with this response, you have the right to make a
complaint to the Ombudsman. Information about how to do this is available
at www.ombudsman.parliament.nz or by phoning 0800 802 602.
Ngâ mihi
Ministerial Services
Government Partnership and Risk
Email: [2][email address]
Te Whatu Ora – Health New Zealand
[3]TeWhatuOra.govt.nz
show quoted sections
References
Visible links
1. mailto:[email address]
2. mailto:[email address]
3. http://scanmail.trustwave.com/?c=15517&a...
Things to do with this request
- Add an annotation (to help the requester or others)
- Download a zip file of all correspondence